"FDA's Proposed Hatch-Waxman Updates – Implications for Generics and Beyond," Northwestern Journal of Technology and Intellectual Property Symposium, Northwestern School of Law, Chicago, IL
Speaking Engagement | 03.11.16
Contacts
Insights
Speaking Engagement | 09.09.26
Speaking Engagement | 06.13.26
Speaking Engagement | 03.17.26
"Economic Substance and Beyond: Federal Tax Controversy and Litigation Update," TEI 2026 Midyear Conference
Speaking Engagement | 03.17.26
"IRA Credits: New Audit Frontier," TEI 2026 Midyear Conference

